Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy

BACKGROUND: Tamoxifen, a selective oestrogen receptor (ER) modulator, increases bone mineral density (BMD) in postmenopausal women and decreases BMD in premenopausal women. We hypothesised that inherited variants in candidate genes involved in oestrogen signalling and tamoxifen metabolism might be a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Henry, N L, Nguyen, A, Azzouz, F, Li, L, Robarge, J, Philips, S, Cao, D, Skaar, T C, Rae, J M, Storniolo, A M, Flockhart, D A, Hayes, D F, Stearns, V
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2010
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2816645/
https://ncbi.nlm.nih.gov/pubmed/19953095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605460
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia